GN Store Nord A/S (GN.CO)

DKK 135.6

(7.45%)

EBITDA Summary of GN Store Nord A/S

  • GN Store Nord A/S's latest annual EBITDA in 2023 was 2.31 Billion DKK , down -20.25% from previous year.
  • GN Store Nord A/S's latest quarterly EBITDA in 2024 Q2 was 700 Million DKK , down -10.83% from previous quarter.
  • GN Store Nord A/S reported an annual EBITDA of 2.49 Billion DKK in 2022, down -23.62% from previous year.
  • GN Store Nord A/S reported an annual EBITDA of 3.59 Billion DKK in 2021, up 29.54% from previous year.
  • GN Store Nord A/S reported a quarterly EBITDA of 781 Million DKK for 2024 Q1, up 98.0% from previous quarter.
  • GN Store Nord A/S reported a quarterly EBITDA of 627 Million DKK for 2023 Q2, up 45.14% from previous quarter.

Annual EBITDA Chart of GN Store Nord A/S (2023 - 2002)

Historical Annual EBITDA of GN Store Nord A/S (2023 - 2002)

Year EBITDA EBITDA Growth
2023 2.31 Billion DKK -20.25%
2022 2.49 Billion DKK -23.62%
2021 3.59 Billion DKK 29.54%
2020 2.81 Billion DKK -11.55%
2019 3.18 Billion DKK 32.85%
2018 2.39 Billion DKK 6.38%
2017 2.29 Billion DKK 6.32%
2016 2.05 Billion DKK 8.42%
2015 1.97 Billion DKK 16.63%
2014 1.68 Billion DKK 15.75%
2013 1.44 Billion DKK 50.98%
2012 967 Million DKK -49.5%
2011 1.73 Billion DKK -36.8%
2010 3.03 Billion DKK 563.02%
2009 529 Million DKK -35.81%
2008 712 Million DKK -15.24%
2007 840 Million DKK 624.14%
2006 675 Million DKK -90.59%
2005 693 Million DKK 4666.67%
2004 1.02 Billion DKK -105.7%
2003 481 Million DKK -94.96%
2002 9.39 Billion DKK 0.0%

Peer EBITDA Comparison of GN Store Nord A/S

Name EBITDA EBITDA Difference
Ambu A/S 691 Million DKK -234.732%
ChemoMetec A/S 193.97 Million DKK -1092.409%
Demant A/S 5.21 Billion DKK 55.673%
Scandinavian Medical Solutions A/S 21.22 Million DKK -10797.329%
ViroGates A/S -12.48 Million DKK 18632.169%